Fast-acting, inhalable insulin is growing in popularity among American adults with diabetes, local Minnesota outlet Fox 9 reported Feb. 1.

Statin therapy reduces the risk of major cardiovascular events across all age ranges, even among people older than 75, according to a meta-analysis published in The Lancet.

Rates of CVD in the U.S. are climbing for the first time in decades, the American Heart Association announced Jan. 31 in its annual heart and stroke statistical update. The organization also said nearly half of the adult U.S. population has some form of heart disease.

A new study in JAMA Cardiology found the most avid exercisers—averaging eight hours per week of vigorous exercise—showed greater levels of coronary artery calcium (CAC). Nevertheless, they were less prone to dying over the average follow-up of 10.4 years compared to participants who exercised less, suggesting they can safely continue their workout regimens. 

Current conversion ratios may be underestimating the long-term cardiotoxicity of common chemotherapy agents like mitoxantrone and overestimating the cardiovascular risk of anthracyclines like daunorubicin, researchers reported in JAMA Oncology Jan. 31.

Full results from the SPRINT MIND trial, published Jan. 28 in JAMA, suggest intensive blood pressure control at a systolic target of less than 120 mm Hg could reduce the likelihood of mild cognitive impairment (MCI) that leads to dementia and Alzheimer’s.

A health plan-wide intervention to switch diabetic patients from costly new insulin products to older, more affordable drugs resulted in a marginal increase in hemoglobin A1c (hbA1c) levels but didn’t change the rate of hospital visits for dangerously high or low blood sugar, researchers reported Jan. 29 in JAMA.

The blood sugar drug dapagliflozin was declared noninferior to placebo in the recent DECLARE-TIMI 58 trial, and while the medication failed to lower rates of major adverse cardiovascular events (MACE) in subjects, it did reduce rates of CV-related death and hospitalizations for heart failure.